Samsara BioCapital GP, LLC - 18 Mar 2025 Form 3 Insider Report for Kalaris Therapeutics, Inc. (KLRS)

Role
10%+ Owner
Signature
Samsara BioCapital GP, LLC, By /s/ Srinivas Akkaraju, Managing Member
Issuer symbol
KLRS
Transactions as of
18 Mar 2025
Net transactions value
$0
Form type
3
Filing time
25 Mar 2025, 19:38:53 UTC
Previous filing
17 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KLRS Common Stock 11,448,081 18 Mar 2025 By Samsara BioCapital, L.P. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities are directly held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. Samsara LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.